First Time Loading...
T

Talis Biomedical Corp
NASDAQ:TLIS

Watchlist Manager
Talis Biomedical Corp
NASDAQ:TLIS
Watchlist
Price: 9.15 USD 0.55% Market Closed
Updated: May 5, 2024

Income Statement

Earnings Waterfall
Talis Biomedical Corp

Revenue
2.2m USD
Cost of Revenue
-2.4m USD
Gross Profit
-176k USD
Operating Expenses
-77.5m USD
Operating Income
-77.7m USD
Other Expenses
2.2m USD
Net Income
-75.5m USD

Income Statement
Talis Biomedical Corp

Rotate your device to view
Income Statement
Currency: USD
Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023
Revenue
Revenue
12
N/A
11
-10%
18
+60%
17
-4%
8
-55%
8
+8%
4
-46%
5
+10%
5
+12%
5
-11%
3
-41%
3
+0%
2
-23%
Gross Profit
Cost of Revenue
0
0
0
0
0
0
(4)
(5)
(6)
(8)
(5)
(4)
(2)
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
(0)
N/A
(1)
-221%
(2)
-42%
(4)
-139%
(2)
+43%
(1)
+63%
(0)
+77%
Operating Income
Operating Expenses
(66)
(102)
(162)
(215)
(215)
(200)
(165)
(127)
(115)
(112)
(99)
(90)
(78)
Selling, General & Administrative
(10)
(13)
(18)
(26)
(35)
(42)
(47)
(46)
(42)
(41)
(35)
(32)
(30)
Research & Development
(57)
(89)
(143)
(190)
(180)
(158)
(118)
(81)
(73)
(71)
(64)
(57)
(48)
Operating Income
(54)
N/A
(91)
-68%
(144)
-58%
(199)
-38%
(207)
-4%
(192)
+8%
(164)
+14%
(127)
+23%
(116)
+9%
(115)
+0%
(101)
+12%
(90)
+11%
(78)
+14%
Pre-Tax Income
Interest Income Expense
0
0
0
0
0
0
0
0
0
0
0
0
0
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
(3)
Total Other Income
(0)
0
0
(0)
(0)
(0)
(0)
0
1
2
3
4
5
Pre-Tax Income
(55)
N/A
(91)
-67%
(144)
-58%
(199)
-38%
(208)
-4%
(192)
+7%
(165)
+14%
(127)
+23%
(115)
+10%
(113)
+1%
(98)
+13%
(86)
+12%
(75)
+12%
Net Income
Income from Continuing Operations
(55)
(91)
(144)
(199)
(208)
(192)
(165)
(127)
(115)
(113)
(98)
(86)
(75)
Net Income (Common)
(1)
N/A
(91)
-12 735%
(144)
-58%
(199)
-38%
(208)
-4%
(192)
+7%
(165)
+14%
(127)
+23%
(115)
+10%
(113)
+1%
(98)
+13%
(86)
+12%
(75)
+12%
EPS (Diluted)
-0.45
N/A
-58.04
-12 798%
-84.35
-45%
-116.18
-38%
-120.68
-4%
-127.17
-5%
-93.51
+26%
-71.82
+23%
-64.45
+10%
-63.48
+2%
-54.63
+14%
-47.14
+14%
-41.48
+12%

See Also

Discover More